Mizuho Markets Cayman’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,264
Closed -$608K 93
2025
Q4
$608K Buy
+11,264
New +$542K 0.03% 81
2023
Q2
Sell
-1,739,189
Closed -$121M 89
2023
Q1
$121M Buy
+1,739,189
New +$123M 4.85% 7

Other funds holding BMY

Mizuho Markets Cayman's BMY Position: Q1 2026 in Review

Mizuho Markets Cayman sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 11,264 shares — an estimated $608K sold.

Mizuho Markets Cayman first reported a position in BMY in Q1 2023 and held it in 2 quarters. The position peaked at $121M in Q1 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Mizuho Markets Cayman reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Mizuho Markets Cayman sold 11,264 Bristol-Myers Squibb shares in Q1 2026, an estimated $608K.
  • Mizuho Markets Cayman first reported a position in Bristol-Myers Squibb in Q1 2023 and held it in 2 quarters.
  • Mizuho Markets Cayman's Bristol-Myers Squibb position peaked at $121M in Q1 2023.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Mizuho Markets Cayman's 13F filing for Q1 2026, filed 13 May 2026.